Earnings History Data for Crinetics Pharmaceuticals, Inc. (CRNX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly, CRN02481 for the treatment of Hyperinsulinemias and CRN01941 for the treatment of Neuroendocrine Tumors which are in clinical stage. Crinetics Pharmaceuticals Inc is based in San Diego, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | AH | CRNX | Crinetics Pharmaceuticals, Inc. | 4,860 | -0.96 | -0.91 | -1.01 | Crinetics Pharmaceuticals GAAP EPS of -$0.96 misses by $0.05 [11/12/2024 4:49 PM] |
58.88 | 0.10 (0.17%) |
58.78 | 0.0 (0.00%) |
25.91 - 62.00 | 1,000,731 | 590,000 | 21,176 | ||
|
||||||||||||||||||
| 08-08-2024 | AH | CRNX | Crinetics Pharmaceuticals, Inc. | 3,960 | -0.94 | -0.86 | -0.94 | Crinetics Pharmaceuticals GAAP EPS of -$0.94 misses by $0.09, revenue of $0.39M misses by $0.08M [8/8/2024 4:32 PM] |
47.66 | -3.09 (-6.08%) |
50.74 | 0.0 (0.00%) |
15.76 - 55.78 | 808,987 | 580,000 | 40,876 | ||
| 09-05-2024 | AH | CRNX | Crinetics Pharmaceuticals, Inc. | 3,320 | -0.93 | -0.84 | -0.85 | Crinetics Pharmaceuticals GAAP EPS of -$0.93 misses by $0.13, revenue of $0.6M beats by $0.42M [5/9/2024 4:16 PM] |
48.12 | -1.30 (-2.63%) |
49.42 | 0.0 (0.00%) |
15.76 - 51.29 | 660,443 | 820,000 | 45,594 | ||
| 28-02-2024 | AH | CRNX | Crinetics Pharmaceuticals | 2,462 | -0.90 | -0.89 | 0.00 | Crinetics Pharmaceuticals GAAP EPS of -$0.90 misses by $0.02 [2/28/2024 4:55 PM] |
41.03 | -1.73 (-4.05%) |
45.16 | 2.40 (5.61%) |
15.23 - 47.48 | 1,032,681 | 630,000 | 2,471 | ||
| 07-11-2023 | AH | CRNX | Crinetics Pharmaceuticals | 1,679 | -1.01 | -0.89 | 0.00 | Crinetics Pharmaceuticals GAAP EPS of -$1.01 misses by $0.15, revenue of $0.35M beats by $0.21M [11/7/2023 5:35 PM] |
28.44 | -1.08 (-3.66%) |
30.00 | 0.48 (1.63%) |
15.23 - 31.41 | 1,283,898 | 870,000 | 125,752 | ||
| 08-08-2023 | PM | CRNX | Crinetics Pharmaceuticals | 1,010 | -0.94 | -0.85 | 0.00 | Crinetics Pharmaceuticals GAAP EPS of -$0.94, revenue of $1M [8/8/2023 8:00 AM] |
17.30 | -0.70 (-3.89%) |
0.0 | 0.0 (0.00%) |
15.23 - 24.58 | 475,568 | 450,000 | 0 | ||
| 04-05-2023 | AH | After the close (May 4) |
CRNX | Crinetics Pharmaceuticals | 1,126 | -0.85 | -0.82 | 0.00 | Crinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43M [5/4/2023 5:31 PM] |
22.33 | 0.96 (4.49%) |
21.37 | 0.0 (0.00%) |
15.23 - 24.25 | 1,394,183 | 470,000 | 17,496 | |
| 28-02-2023 | AH | CRNX | Crinetics Pharmaceuticals | 1,052 | -0.84 | -0.82 | 0.00 | Crinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41M [2/28/2023 5:46 PM] |
19.59 | -0.05 (-0.25%) |
19.64 | 0.0 (0.00%) |
15.37 - 27.86 | 565,152 | 360,000 | 319,814 | ||
| 12-08-2022 | PM | CRNX | Crinetics Pharmaceuticals | 1,165 | -0.81 | -0.62 | 0.00 | Crinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15, revenue of $0.44M misses by $0.28M [8/12/2022 8:28 AM] |
20.57 | -0.02 (-0.10%) |
20.29 | -0.30 (-1.46%) |
15.91 - 28.95 | 587,556 | 270,000 | 100 | ||
| 10-08-2021 | AH | CRNX | Crinetics Pharmaceuticals, Inc. | 662.00 | -0.70 | -0.60 | 0.00 | Crinetics Pharmaceuticals EPS misses by $0.10 [8/10/2021 4:48 PM] |
19.18 | 1.58 (8.98%) |
19.00 | 1.40 (7.95%) |
11.61 - 21.64 | 566,112 | 130,000 | 734 | ||
|
||||||||||||||||||
| 06-05-2021 | AH | CRNX | Crinetics Pharmaceuticals, Inc. | 662.00 | -0.69 | -0.65 | 0.00 | Crinetics Pharmaceuticals EPS misses by $0.04 [5/6/2021 5:12 PM] |
16.94 | 0.29 (1.74%) |
0.0 | 0.0 (0.00%) |
11.61 - 23.70 | 53,373 | 90,000 | 0 | ||
| 30-03-2021 | AH | 4:10 PM ET (Mar 30) |
CRNX | Crinetics Pharmaceuticals, Inc. | 521.16 | -0.66 | -0.58 | -0.60 | Crinetics Pharmaceuticals EPS misses by $0.08 [3/30/2021 4:23 PM] |
15.29 | -0.15 (-0.97%) |
15.44 | 0.0 (0.00%) |
11.61 - 23.70 | 86,820 | 120,000 | 3,295 | |